EC TSE Standards Adoption Vital For Policy Harmonization - MDMA
This article was originally published in The Gray Sheet
Executive Summary
The European Commission and EU member state experts should rapidly adopt the EC's draft decision on transmissible spongiform encephalopathies (TSEs) and medical devices that incorporate animal materials, the Medical Device Manufacturers Association says in a March 14 letter to EC Commissioner Erkki Liikanen.
You may also be interested in...
EU State Actions On BSE Must Be Unified Through CEC Decision - EUCOMED
EUCOMED is urging the Commission of European Communities to finalize its draft decision on medical devices incorporating materials of animal origin in order to head off further individual actions by member states.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.